Oklahoma 2025 2025 Regular Session

Oklahoma Senate Bill SB552 Amended / Bill

Filed 02/17/2025

                     
 
SENATE FLOOR VERSION - SB552 SFLR 	Page 1 
(Bold face denotes Committee Amendments)  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
SENATE FLOOR VERSION 
February 13, 2025 
 
 
SENATE BILL NO. 552 	By: Hines 
 
 
 
 
 
An Act relating to public safety; defining terms; 
prohibiting state agencies from certain use of 
biotechnology; prohibiting certain contract; 
providing for codification; and provid ing conditional 
effective date. 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 52 of Title 74, unless there is 
created a duplication in numbering, reads as follows: 
A.  For purposes of this section: 
1.  “Biotechnology company of concern ” means an entity 
designated by the federal government to be under the control of a 
foreign adversary and that poses a risk to national security base d 
on the company’s research of multiomic data collection; and 
2.  “Multiomics” means a biological analysis method that 
combines data from multiple research areas, including, but not 
limited to, genomics, tra nscriptomics, proteomics, epigenomics, and 
metabolomics in order to gain a comprehensive understanding of 
complex biological processes .   
 
SENATE FLOOR VERSION - SB552 SFLR 	Page 2 
(Bold face denotes Committee Amendments)  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
B.  Any state agency that receives federal or state funds shall 
not be authorized to use or procure any biotechnology equipment or 
service that originates from a company designated by the federal 
government to be a biotechnology company of concern nor shall any 
such state agency contract with an entity that uses or procures such 
biotechnology. 
SECTION 2.  This act shall take effect upon the enactment of a 
federal law that prohibits entities that receive federal funds from 
using biotechnology that is from a company associated with a foreign 
adversary. 
COMMITTEE REPORT BY: COMMITTEE ON TECHNOLOGY AND TELECOMMUNICATIONS 
February 13, 2025 - DO PASS